Editorial: Challenges in developing new multiple sclerosis therapies

by Michael K. Racke
Published 2008-09-01

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis

by Michael K. Racke, Olaf Stüve
Published 2008-11-01

PPARs in Neuroinflammation

by Paul D. Drew, Michael K. Racke
Published 2008-01-01

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs

by Yuhong Yang, Amy E. Lovett-Racke, Michael K. Racke
Published 2010-01-01

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

by Michael K. Racke, Paul D. Drew, Amy Lovett-Racke, Yuhong Yang, Anne R. Gocke
Published 2008-01-01

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

by Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson
Published 2008-01-01

A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in e...

by Gina M. Remington, Katherine Treadaway, Teresa Frohman, Amber Salter, Olaf Stüve, Michael K. Racke, Kathleen Hawker, Federica Agosta, Maria Pia Sormani, Massimo Filippi, Elliot M. Frohman
Published 2010-01-01

PEG minocycline-liposomes ameliorate CNS autoimmune disease.

by Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve
Published 2009-01-01

A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance

by Saba I. Aqel, Xiaozhi Yang, Emma E. Kraus, Jinhua Song, Marissa F. Farinas, Erin Y. Zhao, Wei Pei, Amy E. Lovett-Racke, Michael K. Racke, Chenglong Li, Yuhong Yang
Published 2021-02-01

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

by Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar
Published 2011-02-01

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler...

by Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov
Published 2010-01-01